179 related articles for article (PubMed ID: 24711083)
1. Effective TRAIL-based immunotherapy requires both plasmacytoid and CD8α dendritic cells.
James BR; Brincks EL; Kucaba TA; Boon L; Griffith TS
Cancer Immunol Immunother; 2014 Jul; 63(7):685-97. PubMed ID: 24711083
[TBL] [Abstract][Full Text] [Related]
2. Eradication of metastatic renal cell carcinoma after adenovirus-encoded TNF-related apoptosis-inducing ligand (TRAIL)/CpG immunotherapy.
Norian LA; Kresowik TP; Rosevear HM; James BR; Rosean TR; Lightfoot AJ; Kucaba TA; Schwarz C; Weydert CJ; Henry MD; Griffith TS
PLoS One; 2012; 7(2):e31085. PubMed ID: 22312440
[TBL] [Abstract][Full Text] [Related]
3. Activation of tumor-specific CD8+ T Cells after intratumoral Ad5-TRAIL/CpG oligodeoxynucleotide combination therapy.
VanOosten RL; Griffith TS
Cancer Res; 2007 Dec; 67(24):11980-90. PubMed ID: 18089829
[TBL] [Abstract][Full Text] [Related]
4. CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma.
James BR; Anderson KG; Brincks EL; Kucaba TA; Norian LA; Masopust D; Griffith TS
Cancer Immunol Immunother; 2014 Nov; 63(11):1213-27. PubMed ID: 25143233
[TBL] [Abstract][Full Text] [Related]
5. CX3CR1+ CD8alpha+ dendritic cells are a steady-state population related to plasmacytoid dendritic cells.
Bar-On L; Birnberg T; Lewis KL; Edelson BT; Bruder D; Hildner K; Buer J; Murphy KM; Reizis B; Jung S
Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14745-50. PubMed ID: 20679228
[TBL] [Abstract][Full Text] [Related]
6. Induction of CTL and nonpolarized Th cell responses by CD8alpha(+) and CD8alpha(-) dendritic cells.
Schlecht G; Leclerc C; Dadaglio G
J Immunol; 2001 Oct; 167(8):4215-21. PubMed ID: 11591742
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C Virus Stimulates Murine CD8α-Like Dendritic Cells to Produce Type I Interferon in a TRIF-Dependent Manner.
Pfaender S; Grabski E; Detje CN; Riebesehl N; Lienenklaus S; Steinmann E; Kalinke U; Pietschmann T
PLoS Pathog; 2016 Jul; 12(7):e1005736. PubMed ID: 27385030
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytoid dendritic cell-derived IFN-alpha induces TNF-related apoptosis-inducing ligand/Apo-2L-mediated antitumor activity by human monocytes following CpG oligodeoxynucleotide stimulation.
Kemp TJ; Elzey BD; Griffith TS
J Immunol; 2003 Jul; 171(1):212-8. PubMed ID: 12817000
[TBL] [Abstract][Full Text] [Related]
9. Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.
Suleman M; Galea S; Gavard F; Merillon N; Klonjkowski B; Tartour E; Richardson J
Vaccine; 2011 Aug; 29(35):5892-903. PubMed ID: 21723900
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of monocytic cell clones into CD8 alpha+ dendritic cells (DC) suggests that monocytes can be direct precursors for both CD8 alpha+ and CD8 alpha- DC in the mouse.
Gao JX; Liu X; Wen J; Zhang H; Durbin J; Liu Y; Zheng P
J Immunol; 2003 Jun; 170(12):5927-35. PubMed ID: 12794119
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal changes in CD11c
Yadav PK; Chandrakar P; Sharma P; Vishwakarma P; Parmar N; Srivastava M; Kar S
Vaccine; 2020 Jan; 38(2):355-365. PubMed ID: 31648908
[TBL] [Abstract][Full Text] [Related]
12. Clec9A
Gilfillan CB; Kuhn S; Baey C; Hyde EJ; Yang J; Ruedl C; Ronchese F
J Immunol; 2018 Apr; 200(8):2978-2986. PubMed ID: 29507107
[TBL] [Abstract][Full Text] [Related]
13. Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells.
Nierkens S; den Brok MH; Garcia Z; Togher S; Wagenaars J; Wassink M; Boon L; Ruers TJ; Figdor CG; Schoenberger SP; Adema GJ; Janssen EM
Cancer Res; 2011 Oct; 71(20):6428-37. PubMed ID: 21788345
[TBL] [Abstract][Full Text] [Related]
14. Tumor antigen-pulsed CD8α(+) dendritic cells induce T cell-mediated graft-versus-tumor effect in vitro.
Na N; Chen K; Zhang J; He S; Fu Q; Zhu B; Cao K; Xu L
J Huazhong Univ Sci Technolog Med Sci; 2011 Dec; 31(6):728-734. PubMed ID: 22173490
[TBL] [Abstract][Full Text] [Related]
15. Cytokines regulate the capacity of CD8alpha(+) and CD8alpha(-) dendritic cells to prime Th1/Th2 cells in vivo.
Maldonado-López R; Maliszewski C; Urbain J; Moser M
J Immunol; 2001 Oct; 167(8):4345-50. PubMed ID: 11591758
[TBL] [Abstract][Full Text] [Related]
16. Biphasic function of TLR3 adjuvant on tumor and spleen dendritic cells promotes tumor T cell infiltration and regression in a vaccine therapy.
Azuma M; Takeda Y; Nakajima H; Sugiyama H; Ebihara T; Oshiumi H; Matsumoto M; Seya T
Oncoimmunology; 2016 Aug; 5(8):e1188244. PubMed ID: 27622060
[TBL] [Abstract][Full Text] [Related]
17. Adoptive transfer of CD8alpha+ dendritic cells (DC) isolated from mice infected with Chlamydia muridarum are more potent in inducing protective immunity than CD8alpha- DC.
Bilenki L; Wang S; Yang J; Fan Y; Jiao L; Joyee AG; Han X; Yang X
J Immunol; 2006 Nov; 177(10):7067-75. PubMed ID: 17082623
[TBL] [Abstract][Full Text] [Related]
18. TLR7 ligand augments GM-CSF-initiated antitumor immunity through activation of plasmacytoid dendritic cells.
Narusawa M; Inoue H; Sakamoto C; Matsumura Y; Takahashi A; Inoue T; Watanabe A; Miyamoto S; Miura Y; Hijikata Y; Tanaka Y; Inoue M; Takayama K; Okazaki T; Hasegawa M; Nakanishi Y; Tani K
Cancer Immunol Res; 2014 Jun; 2(6):568-80. PubMed ID: 24830413
[TBL] [Abstract][Full Text] [Related]
19. Invariant NKT cells preferentially modulate the function of CD8 alpha+ dendritic cell subset in inducing type 1 immunity against infection.
Joyee AG; Uzonna J; Yang X
J Immunol; 2010 Feb; 184(4):2095-106. PubMed ID: 20089704
[TBL] [Abstract][Full Text] [Related]
20. Distinct responses of splenic dendritic cell subsets to infection with Listeria monocytogenes: maturation phenotype, level of infection, and T cell priming capacity ex vivo.
Mitchell LM; Brzoza-Lewis KL; Henry CJ; Grayson JM; Westcott MM; Hiltbold EM
Cell Immunol; 2011; 268(2):79-86. PubMed ID: 21457950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
